Furthermore, validated target genes of miR-222-3p and miR-409-3p include PPP2R2A, RECK, and MGMT, all implicated in T2D and GDM pathophysiology [45,46,47]. The gene discussed is MGMT; the disease is type 2 diabetes mellitus.